Ketogenic Diet Enhances CAR T Cell Antitumor Function Via β-Hydroxybutyrate
Shan Liu(University of Pennsylvania), Marco Ruella(University of Pennsylvania), Ruchi P. Patel(Parker Institute for Cancer Immunotherapy), Alberto Carturan(Hospital of the University of Pennsylvania), Giulia Gabrielli(University of Turin), Amichay Afriat(Princeton University), Ma’ayan Levy(University of Pennsylvania), Andre Kelly(University of Pennsylvania), Guido Ghilardi(Hospital of the University of Pennsylvania), Lev Litichevskiy(University of Pennsylvania), Alana M. McSween(Stanford University), Roddy S. O’Connor(University of Pennsylvania), Luca Paruzzo(Hospital of the University of Pennsylvania), Neil Tangal(University of Pennsylvania), Puneeth Guruprasad(Parker Institute for Cancer Immunotherapy), Bhoomi Madhu(University of Pennsylvania), Joshua D. Rabinowitz(Princeton University), Andrew S. Lee(University of Pennsylvania), Patrizia Porazzi(Sidney Kimmel Cancer Center), Melody T. Tan(Parker Institute for Cancer Immunotherapy), Stephen J. Schuster(UPMC Hillman Cancer Center), Raymone Pajarillo(Hospital of the University of Pennsylvania), Michael C. Milone(University of Pennsylvania), Yunlin Zhang(Hospital of the University of Pennsylvania), K. Han(University of Pennsylvania), Alexander A. Shestov(California University of Pennsylvania), Ezra Dubowitz(University of Pennsylvania), Kevin R. Amses(University of Pennsylvania)
Cited by 9
Related Papers
Glucose feeds the TCA cycle via circulating lactate
|Nature|2017|1.7k
Ibrutinib versus Ofatumumab in Previously Treated Chronic Lymphoid Leukemia
|New England Journal of Medicine|2014|1.6k
A roadmap for interpreting 13C metabolite labeling patterns from cells
|Current Opinion in Biotechnology|2015|652
Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies
|Journal of Clinical Investigation|2016|554
The pentose phosphate pathway in health and disease
|Nature Metabolism|2023|524